Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 65

1.

Can we identify individuals with an ALPL variant in adults with persistent hypophosphatasaemia?

Tornero C, Navarro-Compán V, Tenorio JA, García-Carazo S, Buño A, Monjo I, Plasencia-Rodriguez C, Iturzaeta JM, Lapunzina P, Heath KE, Balsa A, Aguado P.

Orphanet J Rare Dis. 2020 Feb 17;15(1):51. doi: 10.1186/s13023-020-1315-y.

PMID:
32066479
2.

Comparative results of the implementation in daily practice of an evaluation checklist for patients with axial spondyloarthritis and psoriatic arthritis.

Almodovar R, Joven B, Rodríguez Almaraz E, Melchor S, Rabadán E, Villaverde V, Navío T, Cebrián Méndez L, Lojo Oliveira L, Prada A, González L, García Martos Á, Navarro-Compán V, Loza E, Zarco P.

Reumatol Clin. 2020 Feb 6. pii: S1699-258X(20)30007-3. doi: 10.1016/j.reuma.2019.11.005. [Epub ahead of print] English, Spanish.

3.

Ankylosing Spondylitis Physical Performance Index (ASPI): objective test for physical functioning is highly reliable and feasible.

van Bentum RE, Ibañez Vodnizza SE, de la Fuente MPP, Valenzuela Aldridge F, Navarro-Compán V, Rusman TR, Ter Wee MM, Valenzuela Letelier O, van Weely SFE, van der Horst-Bruinsma IE.

J Rheumatol. 2020 Feb 1. pii: jrheum.191063. doi: 10.3899/jrheum.191063. [Epub ahead of print]

PMID:
32007935
4.

Are we treating women patients with real axial spondyloarthritis?

Nieto RE, Plasencia Rodriguez C, Peiteado López D, Villalba Yllán A, Balsa Criado A, Navarro-Compán V.

Semin Arthritis Rheum. 2019 Nov 14. pii: S0049-0172(19)30699-7. doi: 10.1016/j.semarthrit.2019.11.011. [Epub ahead of print]

PMID:
31812352
5.

Development of ASAS quality standards to improve the quality of health and care services for patients with axial spondyloarthritis.

Kiltz U, Landewé RBM, van der Heijde D, Rudwaleit M, Weisman MH, Akkoc N, Boonen A, Brandt J, Carron P, Dougados M, Gossec L, Jongkees M, Machado PM, Marzo-Ortega H, Molto A, Navarro-Compán V, Niederman K, Sampaio-Barros PD, Slobodin G, Van den Bosch FE, van Tubergen A, van Weely S, Wiek D, Braun J.

Ann Rheum Dis. 2020 Feb;79(2):193-201. doi: 10.1136/annrheumdis-2019-216034. Epub 2019 Oct 11.

6.

Low serum calprotectin levels correlate with the presence of biological drugs after the first year of treatment in patients with rheumatoid arthritis.

Martínez-Feito A, Plasencia-Rodríguez C, Navarro-Compán V, Jochems A, Hernández-Breijo B, Peiteado D, Tornero C, Pascual-Salcedo D, Balsa A.

Scand J Clin Lab Invest. 2019 Nov;79(7):538-540. doi: 10.1080/00365513.2019.1669813. Epub 2019 Sep 27. No abstract available.

PMID:
31561717
7.

Magnetic resonance imaging assessment in patients with axial spondyloarthritis: development of checklists for use in clinical practice.

Almodóvar R, Bueno Á, Batlle E, Beltrán-Catalán E, Bernabeu D, Castro Copete C, Cepero A, Crespo C, Díez F, Fernández-Carballido C, García Lorente F, Gil De Miguel A, Juanola X, Linares L, Montero Pérez-Barquero R, Castro C, Moreno Ramos MJ, Moreno M, Navarro-Compán V, Pack C, Quiles C, Veintemillas M, Zarco P.

Rheumatol Int. 2019 Dec;39(12):2119-2127. doi: 10.1007/s00296-019-04441-2. Epub 2019 Sep 18.

PMID:
31535169
8.

MRI lesions in the sacroiliac joints of patients with spondyloarthritis: an update of definitions and validation by the ASAS MRI working group.

Maksymowych WP, Lambert RG, Østergaard M, Pedersen SJ, Machado PM, Weber U, Bennett AN, Braun J, Burgos-Vargas R, de Hooge M, Deodhar AA, Eshed I, Jurik AG, Hermann KA, Landewé RB, Marzo-Ortega H, Navarro-Compán V, Poddubnyy D, Reijnierse M, Rudwaleit M, Sieper J, Van den Bosch FE, van der Heijde D, van der Horst-Bruinsma IE, Wichuk S, Baraliakos X.

Ann Rheum Dis. 2019 Nov;78(11):1550-1558. doi: 10.1136/annrheumdis-2019-215589. Epub 2019 Aug 17.

PMID:
31422357
9.

Reduction in antidrug antibody levels after switching to rituximab in patients with rheumatoid arthritis with prior infliximab or adalimumab secondary failure.

Martínez Feito A, Plasencia-Rodríguez C, Navarro-Compán V, Hernández-Breijo B, Nozal P, Ángeles González M, Nuño L, Monjo I, Pascual-Salcedo D, Balsa A.

Semin Arthritis Rheum. 2020 Feb;50(1):E1-E2. doi: 10.1016/j.semarthrit.2019.06.021. Epub 2019 Jun 28. No abstract available.

PMID:
31375255
10.

Implementation of an assessment checklist for patients with spondyloarthritis in daily practice.

Almodovar R, Joven B, Rodríguez Almaraz E, Melchor S, Rabadán E, Villaverde V, Navío T, Cebrián Méndez L, Lojo Oliveira L, Prada A, González L, Navarro-Compán V, Loza E, Zarco P.

Clin Exp Rheumatol. 2020 Jan-Feb;38(1):115-121. Epub 2019 Jun 11.

PMID:
31287409
11.

An Update on Diagnosis and Classification of Axial Spondyloarthritis.

Navarro-Compán V.

Curr Rheumatol Rep. 2019 Jun 15;21(8):39. doi: 10.1007/s11926-019-0838-5. Review.

PMID:
31203462
12.

The European Map of Axial Spondyloarthritis: Capturing the Patient Perspective-an Analysis of 2846 Patients Across 13 Countries.

Garrido-Cumbrera M, Poddubnyy D, Gossec L, Gálvez-Ruiz D, Bundy C, Mahapatra R, Makri S, Christen L, Delgado-Domínguez CJ, Sanz-Gómez S, Plazuelo-Ramos P, Navarro-Compán V; EMAS Working Group.

Curr Rheumatol Rep. 2019 Mar 12;21(5):19. doi: 10.1007/s11926-019-0819-8. Review.

13.

Association between concomitant csDMARDs and clinical response to TNF inhibitors in overweight patients with axial spondyloarthritis.

Hernández-Breijo B, Plasencia-Rodríguez C, Navarro-Compán V, Martínez-Feito A, Jochems A, Kneepkens EL, Wolbink GJ, Rispens T, Diego C, Pascual-Salcedo D, Balsa A.

Arthritis Res Ther. 2019 Feb 20;21(1):66. doi: 10.1186/s13075-019-1849-3.

14.

The Effect of Axial Spondyloarthritis on Mental Health: Results from the Atlas.

Garrido-Cumbrera M, Delgado-Domínguez CJ, Gálvez-Ruiz D, Mur CB, Navarro-Compán V; Atlas Working Group.

J Rheumatol. 2019 Oct;46(10):1284-1289. doi: 10.3899/jrheum.180868. Epub 2019 Feb 15.

PMID:
30770507
15.

The effect of methotrexate versus other disease-modifying anti-rheumatic drugs on serum drug levels and clinical response in patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors.

Martínez-Feito A, Plasencia-Rodríguez C, Navarro-Compán V, Hernández-Breijo B, González MÁ, Monjo I, Nuño L, Nozal P, Pascual-Salcedo D, Balsa A.

Clin Rheumatol. 2019 Mar;38(3):949-954. doi: 10.1007/s10067-018-4355-0. Epub 2018 Nov 6.

PMID:
30402698
16.

Atlas of axial spondyloarthritis in Spain 2017: Study design and population.

Garrido-Cumbrera M, Navarro-Compán V, Zarco P, Collantes-Estévez E, Gálvez-Ruiz D, Braçe O, Chacón García J, Blanch Mur C, Costa Ferrer A, Hidalgo Vega A, Plazuelo Ramos P, Gratacós Masmitja J.

Reumatol Clin. 2019 May - Jun;15(3):127-132. doi: 10.1016/j.reuma.2018.08.003. Epub 2018 Oct 3. English, Spanish.

17.

Assessment of SpondyloArthritis International Society (ASAS) Consensus on Spanish Nomenclature for Spondyloarthritis.

Navarro-Compán V, Otón T, Loza E, Almodóvar R, Ariza-Ariza R, Bautista-Molano W, Burgos-Vargas R, Collantes-Estévez E, de Miguel E, González-Fernández C, Gratacós J, Ibáñez S, Juanola X, Maldonado-Cocco J, Moltó A, Mulero J, Pacheco-Tena C, Ramos-Remus C, Sanz-Sanz J, Valle-Oñate R, Zarco P, Marzo-Ortega H.

Reumatol Clin. 2018 Sep 4. pii: S1699-258X(18)30173-6. doi: 10.1016/j.reuma.2018.07.014. [Epub ahead of print] English, Spanish.

18.

Measurement properties of the ASAS Health Index: results of a global study in patients with axial and peripheral spondyloarthritis.

Kiltz U, van der Heijde D, Boonen A, Akkoc N, Bautista-Molano W, Burgos-Vargas R, Wei JC, Chiowchanwisawakit P, Dougados M, Duruoz MT, Elzorkany BK, Gaydukova I, Gensler LS, Gilio M, Grazio S, Gu J, Inman RD, Kim TJ, Navarro-Compan V, Marzo-Ortega H, Ozgocmen S, Pimentel Dos Santos F, Schirmer M, Stebbings S, Van den Bosch FE, van Tubergen A, Braun J.

Ann Rheum Dis. 2018 Sep;77(9):1311-1317. doi: 10.1136/annrheumdis-2017-212076. Epub 2018 Jun 1.

19.

The EJES-3D tool for personalized prescription of exercise in axial spondyloarthritis through multimedia animations: pilot study.

Flórez MT, Almodóvar R, García Pérez F, Rodríguez Cambrón AB, Carmona L, Pérez Manzanero MÁ, Aboitiz Cantalapiedra J, Urruticoechea-Arana A, Rodríguez Lozano CJ, Castro C, Fernández-Carballido C, de Miguel E, Galíndez E, Álvarez Vega JL, Torre Alonso JC, Linares LF, Moreno M, Navarro-Compán V, Juanola X, Zarco P.

Rheumatol Int. 2018 Jul;38(7):1277-1284. doi: 10.1007/s00296-018-4049-6. Epub 2018 May 21.

PMID:
29786781
20.

Prevalence and characteristics associated with dactylitis in patients with early spondyloarthritis: results from the ESPeranza cohort.

Tévar-Sánchez MI, Navarro-Compán V, Aznar JJ, Linares LF, Castro MC, De Miguel E; ESPERANZA Group.

Clin Exp Rheumatol. 2018 Sep-Oct;36(5):879-883. Epub 2018 May 8.

21.

Should over-treatment of axial spondyloarthritis with biologics remain a concern after the issue of the new ASAS criteria? Data from REGISPONSERBIO (Spanish Register of Biological Therapy in Spondyloarthritides).

Moreno M, Gratacós J, Navarro-Compán V, de Miguel E, Font P, Clavaguera T, Linares LF, Joven B, Juanola X; and the Regisponserbio group.

Clin Exp Rheumatol. 2018 Nov-Dec;36(6):1038-1042. Epub 2018 May 8.

22.

Golimumab Tapering Strategy Based on Serum Drug Levels in Patients With Spondyloarthritis.

Redondo C, Martínez-Feito A, Plasencia-Rodríguez C, Navarro-Compán V, Nuño-Nuño L, Peiteado D, Villalba A, Jochems A, Pascual-Salcedo D, Balsa A.

Arthritis Rheumatol. 2018 Aug;70(8):1356-1358. doi: 10.1002/art.40542. Epub 2018 Jul 2. No abstract available.

23.

Switching biological disease-modifying antirheumatic drugs in patients with axial spondyloarthritis: results from a systematic literature review.

Navarro-Compán V, Plasencia-Rodríguez C, de Miguel E, Diaz Del Campo P, Balsa A, Gratacós J.

RMD Open. 2017 Oct 10;3(2):e000524. doi: 10.1136/rmdopen-2017-000524. eCollection 2017.

24.

Recommendations by the Spanish Society of Rheumatology on the Use of Biological Therapies in Axial Spondyloarthritis.

Gratacós J, Díaz Del Campo Fontecha P, Fernández-Carballido C, Juanola Roura X, Linares Ferrando LF, de Miguel Mendieta E, Muñoz Fernández S, Rosales-Alexander JL, Zarco Montejo P, Guerra Rodríguez M, Navarro Compán V.

Reumatol Clin. 2018 Nov - Dec;14(6):320-333. doi: 10.1016/j.reuma.2017.08.008. Epub 2017 Oct 16. English, Spanish.

25.

Optimal concentration range of golimumab in patients with axial spondyloarthritis.

Martínez-Feito A, Plasencia-Rodriguez C, Navarro-Compán V, Jurado T, Kneepkens EL, Wolbink GJ, Martín S, Ruiz Del Agua A, Navarro R, Mezcua A, Jochems A, Peiteado D, Bonilla MG, Balsa A, Pascual-Salcedo D.

Clin Exp Rheumatol. 2018 Jan-Feb;36(1):110-114. Epub 2017 Sep 15.

PMID:
28980904
26.

Sacroiliac radiographic progression in recent onset axial spondyloarthritis: the 5-year data of the DESIR cohort.

Dougados M, Sepriano A, Molto A, van Lunteren M, Ramiro S, de Hooge M, van den Berg R, Navarro Compan V, Demattei C, Landewé R, van der Heijde D.

Ann Rheum Dis. 2017 Nov;76(11):1823-1828. doi: 10.1136/annrheumdis-2017-211596. Epub 2017 Jul 6.

27.

Development of a checklist for patients with axial spondyloarthritis and psoriatic arthritis in daily practice: ONLY TOOLS project.

Almodovar R, Torre Alonso JC, Batlle E, Castillo C, Collantes-Estevez E, de Miguel E, González S, Gratacós J, Hernández A, Juanola X, Linares LF, Moreno MJ, Moreno M, Navarro-Compán V, Rodríguez Lozano C, Sanz J, Sellas A, Loza E, Zarco P; grupo de trabajo ONLY TOOLS.

Reumatol Clin. 2018 May - Jun;14(3):155-159. doi: 10.1016/j.reuma.2016.12.003. Epub 2017 Mar 9. English, Spanish.

28.

Recommendations for the Use of Ultrasound and Magnetic Resonance in Patients With Spondyloarthritis, Including Psoriatic Arthritis, and Patients With Juvenile Idiopathic Arthritis.

Uson J, Loza E, Möller I, Acebes C, Andreu JL, Batlle E, Bueno Á, Collado P, Fernández-Gallardo JM, González C, Jiménez Palop M, Lisbona MP, Macarrón P, Maymó J, Narváez JA, Navarro-Compán V, Sanz J, Rosario MP, Vicente E, Naredo E.

Reumatol Clin. 2018 Jan - Feb;14(1):27-35. doi: 10.1016/j.reuma.2016.08.008. Epub 2016 Oct 27. English, Spanish.

29.

In patients with axial spondyloarthritis, inflammation on MRI of the spine is longitudinally related to disease activity only in men: 2 years of the axial spondyloarthritis DESIR cohort.

Navarro-Compán V, Ramiro S, Landewé R, Dougados M, Miceli-Richard C, Richette P, van der Heijde D.

Ann Rheum Dis. 2018 Mar;77(3):470-472. doi: 10.1136/annrheumdis-2016-210697. Epub 2017 Mar 3. No abstract available.

PMID:
28258059
30.

Diagnostic Value and Validity of Early Spondyloarthritis Features: Results From a National Spanish Cohort.

Joven BE, Navarro-Compán V, Rosas J, Fernandez Dapica P, Zarco P, de Miguel E; Esperanza Working Group.

Arthritis Care Res (Hoboken). 2017 Jun;69(6):938-942. doi: 10.1002/acr.23017. Epub 2017 May 9.

31.

2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis.

van der Heijde D, Ramiro S, Landewé R, Baraliakos X, Van den Bosch F, Sepriano A, Regel A, Ciurea A, Dagfinrud H, Dougados M, van Gaalen F, Géher P, van der Horst-Bruinsma I, Inman RD, Jongkees M, Kiltz U, Kvien TK, Machado PM, Marzo-Ortega H, Molto A, Navarro-Compàn V, Ozgocmen S, Pimentel-Santos FM, Reveille J, Rudwaleit M, Sieper J, Sampaio-Barros P, Wiek D, Braun J.

Ann Rheum Dis. 2017 Jun;76(6):978-991. doi: 10.1136/annrheumdis-2016-210770. Epub 2017 Jan 13. Review.

PMID:
28087505
32.

Recommendations for the use of ultrasound and magnetic resonance in patients with rheumatoid arthritis.

Möller I, Loza E, Uson J, Acebes C, Andreu JL, Batlle E, Bueno Á, Collado P, Fernández-Gallardo JM, González C, Jiménez Palop M, Lisbona MP, Macarrón P, Maymó J, Narváez JA, Navarro-Compán V, Sanz J, Rosario MP, Vicente E, Naredo E.

Reumatol Clin. 2018 Jan - Feb;14(1):9-19. doi: 10.1016/j.reuma.2016.08.010. Epub 2016 Oct 29. English, Spanish.

33.

Measuring impairments of functioning and health in patients with axial spondyloarthritis by using the ASAS Health Index and the Environmental Item Set: translation and cross-cultural adaptation into 15 languages.

Kiltz U, van der Heijde D, Boonen A, Bautista-Molano W, Burgos-Vargas R, Chiowchanwisawakit P, Duruoz T, El-Zorkany B, Essers I, Gaydukova I, Géher P, Gossec L, Grazio S, Gu J, Khan MA, Kim TJ, Maksymowych WP, Marzo-Ortega H, Navarro-Compán V, Olivieri I, Patrikos D, Pimentel-Santos FM, Schirmer M, van den Bosch F, Weber U, Zochling J, Braun J.

RMD Open. 2016 Oct 4;2(2):e000311. eCollection 2016.

34.

Differences between familial and sporadic early spondyloarthritis: results from the ESPERANZA cohort.

Almodóvar R, Navarro-Compán V, Fernández-Carballido C, Hernández A, De Miguel E, Zarco P; ESPERANZA Study Group.

Clin Exp Rheumatol. 2016 Jul-Aug;34(4):575-80. Epub 2016 Jun 22.

PMID:
27384500
35.

Association between serum dickkopf-1 levels and disease duration in axial spondyloarthritis.

Rubio Vargas R, Melguizo Madrid E, González Rodríguez C, Navarro Sarabia F, Dominguez Quesada C, Ariza Ariza R, Navarro Compán V.

Reumatol Clin. 2017 Jul - Aug;13(4):197-200. doi: 10.1016/j.reuma.2016.04.013. Epub 2016 Jun 11. English, Spanish.

36.

Spondyloarthropathies: Sacroiliac joint radiographic progression - speed and determinants.

Navarro-Compán V, Machado PM.

Nat Rev Rheumatol. 2016 Jul;12(7):380-2. doi: 10.1038/nrrheum.2016.86. Epub 2016 May 26. No abstract available.

PMID:
27225305
37.

Comparing a tapering strategy to the standard dosing regimen of TNF inhibitors in rheumatoid arthritis patients with low disease activity.

Plasencia C, Wolbink G, Krieckaert CL, Kneepkens EL, Turk S, Jurado T, Martínez-Feito A, Navarro-Compán V, Bonilla G, Villalba A, Peiteado D, Nuño L, Martín-Mola E, Nurmohamed MT, van der Kleij D, Rispens T, Pascual-Salcedo D, Balsa A.

Clin Exp Rheumatol. 2016 Jul-Aug;34(4):655-62. Epub 2016 May 19.

PMID:
27214767
38.

Disease Activity As a Major Determinant of Quality of Life and Physical Function in Patients With Early Axial Spondyloarthritis.

Fernández-Carballido C, Navarro-Compán V, Castillo-Gallego C, Castro-Villegas MC, Collantes-Estévez E, de Miguel E; Esperanza Study Group.

Arthritis Care Res (Hoboken). 2017 Jan;69(1):150-155. doi: 10.1002/acr.22908. Epub 2016 Nov 21.

39.

Anti-TNF discontinuation and tapering strategies in patients with axial spondyloarthritis: a systematic literature review.

Navarro-Compán V, Plasencia-Rodríguez C, de Miguel E, Balsa A, Martín-Mola E, Seoane-Mato D, Cañete JD.

Rheumatology (Oxford). 2016 Jul;55(7):1188-94. doi: 10.1093/rheumatology/kew033. Epub 2016 Mar 21. Review.

PMID:
26998860
40.

Preliminary definitions of 'flare' in axial spondyloarthritis, based on pain, BASDAI and ASDAS-CRP: an ASAS initiative.

Gossec L, Portier A, Landewé R, Etcheto A, Navarro-Compán V, Kroon F, van der Heijde D, Dougados M.

Ann Rheum Dis. 2016 Jun;75(6):991-6. doi: 10.1136/annrheumdis-2015-208593. Epub 2016 Feb 4. Review.

PMID:
26847821
41.

Similarities and differences between patients fulfilling axial and peripheral ASAS criteria for spondyloarthritis: Results from the Esperanza Cohort.

del Río-Martínez P, Navarro-Compán V, Díaz-Miguel C, Almodóvar R, Mulero J, De Miguel E; Esperanza Group.

Semin Arthritis Rheum. 2016 Feb;45(4):400-3. doi: 10.1016/j.semarthrit.2015.09.001. Epub 2015 Sep 16.

PMID:
26601781
42.

Disease activity is longitudinally related to sacroiliac inflammation on MRI in male patients with axial spondyloarthritis: 2-years of the DESIR cohort.

Navarro-Compán V, Ramiro S, Landewé R, Dougados M, Miceli-Richard C, Richette P, van der Heijde D.

Ann Rheum Dis. 2016 May;75(5):874-8. doi: 10.1136/annrheumdis-2015-207786. Epub 2015 Sep 24.

PMID:
26403689
43.

Sponyloarthritis features forecasting the presence of HLA-B27 or sacroiliitis on magnetic resonance imaging in patients with suspected axial spondyloarthritis: results from a cross-sectional study in the ESPeranza Cohort.

Navarro-Compán V, de Miguel E, van der Heijde D, Landewé R, Almodóvar R, Montilla C, Beltrán E, Zarco P.

Arthritis Res Ther. 2015 Sep 23;17:265. doi: 10.1186/s13075-015-0779-y.

44.

Erratum to: Is entheses ultrasound reliable? A reading Latin American exercise.

Ventura-Ríos L, Navarro-Compan V, Aliste M, Alva Linares M, Areny R, Audisio M, Bertoli AM, Cazenave T, Cerón C, Díaz ME, Gutiérrez M, Hernández C, Navarta DA, Pineda C, Py GE, Reginato AM, Rosa J, Saaibi DL, Sedano O, Solano C, Castillo-Gallego C, Falçao S, De Miguel E.

Clin Rheumatol. 2016 May;35(5):1359. No abstract available.

PMID:
26316297
45.

Patients with chronic back pain of short duration from the SPACE cohort: which MRI structural lesions in the sacroiliac joints and inflammatory and structural lesions in the spine are most specific for axial spondyloarthritis?

de Hooge M, van den Berg R, Navarro-Compán V, Reijnierse M, van Gaalen F, Fagerli K, Landewé R, van Oosterhout M, Ramonda R, Huizinga T, van der Heijde D.

Ann Rheum Dis. 2016 Jul;75(7):1308-14. doi: 10.1136/annrheumdis-2015-207823. Epub 2015 Aug 18.

PMID:
26286018
46.

Is entheses ultrasound reliable? A reading Latin American exercise.

Ventura-Ríos L, Navarro-Compan V, Aliste M, Linares MA, Areny R, Audisio M, Bertoli AM, Cazenave T, Cerón C, Díaz ME, Gutiérrez M, Hernández C, Navarta DA, Pineda C, Py GE, Reginato AM, Rosa J, Saaibi DL, Sedano O, Solano C, Castillo-Gallego C, Falçao S, De Miguel E.

Clin Rheumatol. 2016 May;35(5):1353-7. doi: 10.1007/s10067-015-3007-x. Epub 2015 Jul 22. Erratum in: Clin Rheumatol. 2016 May;35(5):1359.

PMID:
26198586
47.

Comparing Tapering Strategy to Standard Dosing Regimen of Tumor Necrosis Factor Inhibitors in Patients with Spondyloarthritis in Low Disease Activity.

Plasencia C, Kneepkens EL, Wolbink G, Krieckaert CL, Turk S, Navarro-Compán V, L'Ami M, Nurmohamed MT, van der Horst-Bruinsma I, Jurado T, Diego C, Bonilla G, Villalba A, Peiteado D, Nuño L, van der Kleij D, Rispens T, Martín-Mola E, Balsa A, Pascual-Salcedo D.

J Rheumatol. 2015 Sep;42(9):1638-46. doi: 10.3899/jrheum.141128. Epub 2015 Jul 15.

PMID:
26178279
48.

Evidence for treating rheumatoid arthritis to target: results of a systematic literature search update.

Stoffer MA, Schoels MM, Smolen JS, Aletaha D, Breedveld FC, Burmester G, Bykerk V, Dougados M, Emery P, Haraoui B, Gomez-Reino J, Kvien TK, Nash P, Navarro-Compán V, Scholte-Voshaar M, van Vollenhoven R, van der Heijde D, Stamm TA.

Ann Rheum Dis. 2016 Jan;75(1):16-22. doi: 10.1136/annrheumdis-2015-207526. Epub 2015 May 19. Review. Erratum in: Ann Rheum Dis. 2016 May;75(5):946.

49.

Metric Properties of the SPARCC Score of the Sacroiliac Joints - Data from Baseline, 3-month, and 12-month Followup in the SPACE Cohort.

van den Berg R, de Hooge M, Bakker PA, van Gaalen F, Navarro-Compán V, Fagerli KM, Landewé R, van Oosterhout M, Ramonda R, Reijnierse M, van der Heijde D.

J Rheumatol. 2015 Jul;42(7):1186-93. doi: 10.3899/jrheum.140806. Epub 2015 May 1.

PMID:
25934824
50.

Quality indicators in rheumatoid arthritis: results from the METEOR database.

Navarro-Compán V, Smolen JS, Huizinga TW, Landewé R, Ferraccioli G, da Silva JA, Moots RJ, Kay J, van der Heijde D.

Rheumatology (Oxford). 2015 Sep;54(9):1630-9. doi: 10.1093/rheumatology/kev108. Epub 2015 Apr 14.

PMID:
25877910

Supplemental Content

Loading ...
Support Center